
The search for more effective methods to improve the diagnosis and prediction of diseases is more urgent than ever.
Current processes are time-consuming, expensive, and often not accurate enough. This results in treatment delays and places an unnecessary financial burden on the healthcare system.
For patients with chronic, painful diseases such as psoriatic arthritis or vasculitis, it often takes months to find the optimal medication and dosage. However, innovative approaches can offer solutions: non-invasive biomarkers have the potential to enable faster and less risky diagnoses. At the same time, for example, psychological trauma in children or hemorrhagic complications (bleeding) can be prevented when diagnoses are based on blood or urine biomarkers instead of relying on liver biopsies.